“The rating on JHHS reflects the system’s very strong enterprise profile, evidenced by its excellent reputation as the academic medical center for Johns Hopkins University School of Medicine [and] its solid market position in a sizable and diverse service area,” said S&P analyst Stephen Infranco.
These strengths are “coupled with a consistent financial profile, highlighted by stable, albeit modest, operational performance for the past several years, with expectations for continued modest operating surpluses over the next two years based on management’s projections,” according to Mr. Infranco.
JHHS also shows “adequate liquidity and financial flexibility compared with similarly rated peers.”
The outlook is stable.
More articles on healthcare finance:
Fitch assigns ‘AA-‘ rating to Saint Francis Healthcare System’s bonds
S&P assigns ‘A+’ rating to El Camino Hospital’s bonds
Why these 4 health systems abandoned traditional budgeting
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
